Endocrinology PharmDs Show Value at Nebraska Medicine

By Karen BlumAs the focus of type 2 diabetes management has shifted from lowering hemoglobin A1c (HbA1c) to reducing overall comorbidity risk, pharmacists at Nebraska Medicine are demonstrating their clinical value through the development of an ambulatory care pharmacist service line.“The first thing that we did when I took over in this position [in January 2023] is revamp what it is that the pharmacist did,” said Caressa Trueman, PharmD, BCACP, BC-ADM, an ambulatory care pharmacist